Remove Confidentiality Remove Contracts Remove Inventor Remove Settlement
article thumbnail

Daniel Alexander KC says "no" on indemnity costs, blanket confidentiality orders and permission to appeal in Oxford University Innovation dispute

The IPKat

In the consequentials hearing judgment [2023] EWHC 138 , the Judge dealt with (1) royalty payments; (2) costs; (3) confidentiality; and (4) permission to appeal. Of the most interesting to this Kat was the treatment of costs (well, some of them), confidentiality and permission to appeal. The result being that money was due.

article thumbnail

What is Blockchain Technology and has it been Patented?

Biswajit Sarkar Copyright Blog

Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. An opt-in scheme could address the confidentiality concerns of IP owners.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is Blockchain Technology and has it been Patented?

Biswajit Sarkar Copyright Blog

Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. An opt-in scheme could address the confidentiality concerns of IP owners.

article thumbnail

What is Blockchain Technology and has it been Patented?

Biswajit Sarkar Copyright Blog

Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. An opt-in scheme could address the confidentiality concerns of IP owners.

article thumbnail

Biosimilars 2021 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. . No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. Commercial Launch Date. adalimumab-aqvh.